The pandemic was a unique time in our industry where there was a perfect storm of need, money, collaboration, and trial patients all available in abundance. There was an atmosphere of all hands, and resources, on deck in the race to a COVID-19 vaccine.
Watch Now
During direct compression tablets are manufactured without pre-granulation. Excipients therefore need to be highly effective, controllable and free-flowing.
Watch Now
IIdiopathic multicentric Castleman disease (iMCD) is a hematologic illness involving cytokine-induced lymphoproliferation, systemic inflammation, cytopenias and life-threatening multi-organ dysfunction.
Watch Now
Systechone
Serialization is a great achievement for our industry. However, most executives now realize that it is only part of the solution, and serialization alone cannot solve the escalating problems of counterfeiting and diversion within the pharmaceutical industry. The global value of pharmaceutical counterfeiting is $200B annually. More staggering is that the gray market is forecasted to reach almost $3 trillion by 2022.
Watch Now